146 related articles for article (PubMed ID: 10705388)
1. A mouse model of aerosol-transmitted orthopoxviral disease: morphology of experimental aerosol-transmitted orthopoxviral disease in a cowpox virus-BALB/c mouse system.
Martinez MJ; Bray MP; Huggins JW
Arch Pathol Lab Med; 2000 Mar; 124(3):362-77. PubMed ID: 10705388
[TBL] [Abstract][Full Text] [Related]
2. Clinical course and pathology in rats (Rattus norvegicus) after experimental cowpox virus infection by percutaneous and intranasal application.
Breithaupt A; Kalthoff D; Deutskens F; König P; Hoffmann B; Beer M; Meyer H; Teifke JP
Vet Pathol; 2012 Nov; 49(6):941-9. PubMed ID: 22411549
[TBL] [Abstract][Full Text] [Related]
3. Exposure of rhesus monkeys to cowpox virus Brighton Red by large-particle aerosol droplets results in an upper respiratory tract disease.
Johnson RF; Hammoud DA; Perry DL; Solomon J; Moore IN; Lackemeyer MG; Bohannon JK; Sayre PJ; Minai M; Papaneri AB; Hagen KR; Janosko KB; Jett C; Cooper K; Blaney JE; Jahrling PB
J Gen Virol; 2016 Aug; 97(8):1942-1954. PubMed ID: 27166137
[TBL] [Abstract][Full Text] [Related]
4. [Intranasal infection in mice inoculated with cowpox virus strain EP-2 isolated from the elephant].
Vinogradov IV; Kochneva GV; Malkova EM; Shchelkunov SN; Riabchikova EI
Vopr Virusol; 2005; 50(4):37-42. PubMed ID: 16104522
[TBL] [Abstract][Full Text] [Related]
5. Treatment of aerosolized cowpox virus infection in mice with aerosolized cidofovir.
Bray M; Martinez M; Kefauver D; West M; Roy C
Antiviral Res; 2002 Jun; 54(3):129-42. PubMed ID: 12062386
[TBL] [Abstract][Full Text] [Related]
6. Intranasal treatment of cowpox virus respiratory infections in mice with cidofovir.
Smee DF; Bailey KW; Wong M; Sidwell RW
Antiviral Res; 2000 Sep; 47(3):171-7. PubMed ID: 10974369
[TBL] [Abstract][Full Text] [Related]
7. Small particle aerosol inoculation of cowpox Brighton Red in rhesus monkeys results in a severe respiratory disease.
Johnson RF; Hammoud DA; Lackemeyer MG; Yellayi S; Solomon J; Bohannon JK; Janosko KB; Jett C; Cooper K; Blaney JE; Jahrling PB
Virology; 2015 Jul; 481():124-35. PubMed ID: 25776759
[TBL] [Abstract][Full Text] [Related]
8. Differential pathogenesis of cowpox virus intranasal infections in mice induced by low and high inoculum volumes and effects of cidofovir treatment.
Smee DF; Gowen BB; Wandersee MK; Wong MH; Skirpstunas RT; Baldwin TJ; Hoopes JD; Sidwell RW
Int J Antimicrob Agents; 2008 Apr; 31(4):352-9. PubMed ID: 18206353
[TBL] [Abstract][Full Text] [Related]
9. Cidofovir protects mice against lethal aerosol or intranasal cowpox virus challenge.
Bray M; Martinez M; Smee DF; Kefauver D; Thompson E; Huggins JW
J Infect Dis; 2000 Jan; 181(1):10-9. PubMed ID: 10608745
[TBL] [Abstract][Full Text] [Related]
10. Aerosolized cidofovir is retained in the respiratory tract and protects mice against intranasal cowpox virus challenge.
Roy CJ; Baker R; Washburn K; Bray M
Antimicrob Agents Chemother; 2003 Sep; 47(9):2933-7. PubMed ID: 12936997
[TBL] [Abstract][Full Text] [Related]
11. Establishment of BALB/C mouse models of influenza A H1N1 aerosol inhalation.
Hao XY; Li FD; Lv Q; Xu YF; Han YL; Gao H
J Med Virol; 2019 Nov; 91(11):1918-1929. PubMed ID: 31317548
[TBL] [Abstract][Full Text] [Related]
12. [An experimental infection caused by the EP-2 strain of cowpox virus in mice of different ages].
Vinogradov IV; Kochneva GV; Malkova EM; Shchelkunov SN; Riabchikova EI
Vopr Virusol; 2003; 48(5):34-8. PubMed ID: 14598479
[TBL] [Abstract][Full Text] [Related]
13. Canine H3N8 influenza virus infection in dogs and mice.
Castleman WL; Powe JR; Crawford PC; Gibbs EP; Dubovi EJ; Donis RO; Hanshaw D
Vet Pathol; 2010 May; 47(3):507-17. PubMed ID: 20351357
[TBL] [Abstract][Full Text] [Related]
14. Cowpox virus infection of cynomolgus macaques as a model of hemorrhagic smallpox.
Johnson RF; Yellayi S; Cann JA; Johnson A; Smith AL; Paragas J; Jahrling PB; Blaney JE
Virology; 2011 Sep; 418(2):102-12. PubMed ID: 21840027
[TBL] [Abstract][Full Text] [Related]
15. Treatment of cowpox virus respiratory infections in mice with ribavirin as a single agent or followed sequentially by cidofovir.
Smee DF; Bailey KW; Sidwell RW
Antivir Chem Chemother; 2000 Jul; 11(4):303-9. PubMed ID: 10950392
[TBL] [Abstract][Full Text] [Related]
16. Treatment of lethal cowpox virus respiratory infections in mice with 2-amino-7-[(1,3-dihydroxy-2-propoxy)methyl]purine and its orally active diacetate ester prodrug.
Smee DF; Bailey KW; Sidwell RW
Antiviral Res; 2002 May; 54(2):113-20. PubMed ID: 12062396
[TBL] [Abstract][Full Text] [Related]
17. A-type inclusion bodies: a factor influencing cowpox virus lesion pathogenesis.
Leite JA; da Fonseca FG; de Souza Trindade G; Abrahão JS; Arantes RM; de Almeida-Leite CM; dos Santos JR; Guedes MI; Ribeiro BM; Bonjardim CA; Ferreira PC; Kroon EG
Arch Virol; 2011 Apr; 156(4):617-28. PubMed ID: 21212997
[TBL] [Abstract][Full Text] [Related]
18. Elimination of A-type inclusion formation enhances cowpox virus replication in mice: implications for orthopoxvirus evolution.
Kastenmayer RJ; Maruri-Avidal L; Americo JL; Earl PL; Weisberg AS; Moss B
Virology; 2014 Mar; 452-453():59-66. PubMed ID: 24606683
[TBL] [Abstract][Full Text] [Related]
19. Effects of deletions of kelch-like genes on cowpox virus biological properties.
Kochneva G; Kolosova I; Maksyutova T; Ryabchikova E; Shchelkunov S
Arch Virol; 2005 Sep; 150(9):1857-70. PubMed ID: 15824883
[TBL] [Abstract][Full Text] [Related]
20. The pathology of experimental aerosolized monkeypox virus infection in cynomolgus monkeys (Macaca fascicularis).
Zaucha GM; Jahrling PB; Geisbert TW; Swearengen JR; Hensley L
Lab Invest; 2001 Dec; 81(12):1581-600. PubMed ID: 11742030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
